Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine.

de Montjoye, Laurence;Marot, Lilianne;Baeck, Marie
(2022) Journal of the European Academy of Dermatology and Venereology — Vol. 36, n° 1, p. e26-e28 (2022)

Files

AcadDermatolVenereol-2021-Montjoye-EosinophiliccellulitisafterBNT162b2mRNACovid19vaccine.pdf
  • Open Access
  • Adobe PDF
  • 1.39 MB
Download

Details

Authors
Abstract
(en) DEAR EDITOR, We observed a case of eosinophilic cellulitis or Wells syndrome after the BNT162b2 vaccine. A 71-year-old woman with a history of treated high blood pressure and atrial fibrillation presented with a painful eruption of the right arm and forearm. Symptoms started the day following the second dose of the BNT162b2 COVID-19 vaccine (Pfizer/BioNTech) with a localized injection site reaction that progressively worsened. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

de Montjoye, L., Marot, L., & Baeck, M. (2022). Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine. Journal of the European Academy of Dermatology and Venereology, 36(1), e26-e28. https://doi.org/10.1111/jdv.17685 (Original work published 2022)